{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "14660006", "DateCompleted": {"Year": "2004", "Month": "08", "Day": "16"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "15"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0014-2999", "JournalIssue": {"Volume": "482", "Issue": "1-3", "PubDate": {"Year": "2003", "Month": "Dec", "Day": "15"}}, "Title": "European journal of pharmacology", "ISOAbbreviation": "Eur J Pharmacol"}, "ArticleTitle": "Differential involvement of protein kinase C in human promyelocytic leukemia cell differentiation enhanced by artemisinin.", "Pagination": {"StartPage": "67", "EndPage": "76", "MedlinePgn": "67-76"}, "Abstract": {"AbstractText": ["Artemisinin, a sesquiterpene lactone endoperoxide that exists in several medicinal plants, is a well-known anti-malarial agent. In this report, we investigated the effect of artemisinin on cellular differentiation in the human promyelocytic leukemia HL-60 cell culture system. Artemisinin markedly increased the degree of HL-60 leukemia cell differentiation when simultaneously combined with low doses of 1 alpha,25-dihydoxyvitamin D(3) [1,25-(OH)(2)D(3)] or all-trans retinoic acid (all-trans RA). Artemisinin by itself had very weak effects on the differentiation of HL-60 cells. Cytofluorometric analysis and cell morphologic studies indicated that artemisinin potentiated 1,25-(OH)(2)D(3)-induced cell differentiation predominantly into monocytes and all-trans RA-induced cell differentiation into granulocytes, respectively. Extracellular-regulated kinase (ERK) inhibitors markedly inhibited HL-60 cell differentiation induced by artemisinin in combination with 1,25-(OH)(2)D(3) or all-trans RA, whereas phosphatidylinositol 3-kinase (PI3-K) inhibitors did not. Particularly, protein kinase C (PKC) inhibitors inhibited HL-60 cell differentiation induced by artemisinin in combination with 1,25-(OH)(2)D(3) but not with all-trans RA. Artemisinin enhanced PKC activity and protein level of PKC beta I isoform in only 1,25-(OH)(2)D(3)-treated HL-60 cells. Taken together, these results indicate that artemisinin strongly enhanced 1,25-(OH)(2)D(3)- and all-trans RA-induced cell differentiation in which PKC is differentially involved in arteminisin-mediated enhancement of leukemia cell differentiation."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Kwangju 500-757, South Korea."}], "Identifier": [], "LastName": "Kim", "ForeName": "Seung Hyun", "Initials": "SH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "Hyeong Joon", "Initials": "HJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "Tae Sung", "Initials": "TS"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Eur J Pharmacol", "NlmUniqueID": "1254354", "ISSNLinking": "0014-2999"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Artemisinins"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "25X51I8RD4", "NameOfSubstance": "Niacinamide"}, {"RegistryNumber": "5688UTC01R", "NameOfSubstance": "Tretinoin"}, {"RegistryNumber": "9RMU91N5K2", "NameOfSubstance": "artemisinin"}, {"RegistryNumber": "EC 2.7.11.13", "NameOfSubstance": "Protein Kinase C"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Artemisinins"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Cell Differentiation"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Drug Synergism"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": [], "DescriptorName": "HL-60 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["enzymology", "pathology"], "DescriptorName": "Leukemia, Promyelocytic, Acute"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Niacinamide"}, {"QualifierName": ["antagonists & inhibitors", "physiology"], "DescriptorName": "Protein Kinase C"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sesquiterpenes"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Tretinoin"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2003", "Month": "12", "Day": "9", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "8", "Day": "18", "Hour": "5", "Minute": "0"}, {"Year": "2003", "Month": "12", "Day": "9", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["14660006", "10.1016/j.ejphar.2003.09.057", "S0014299903024890"]}}], "PubmedBookArticle": []}